PROS1 and COVID-19: In two recent pioneering studies, monoclonal antibodies isolated from convalescent COVID-19 patients were found to interact specifically with the NTD of the S protein, reinforcing that the mutations in the solvent-exposed epitope regions could confer antibody resistance [28,29].